These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 9771742)

  • 21. PrP(Sc) typing by N-terminal sequencing and mass spectrometry.
    Chen SG; Zou W; Parchi P; Gambetti P
    Arch Virol Suppl; 2000; (16):209-16. PubMed ID: 11214924
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prion protein activates and fixes complement directly via the classical pathway: implications for the mechanism of scrapie agent propagation in lymphoid tissue.
    Mitchell DA; Kirby L; Paulin SM; Villiers CL; Sim RB
    Mol Immunol; 2007 Apr; 44(11):2997-3004. PubMed ID: 17337056
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protein-based PCR for prion diseases?
    Telling G
    Nat Med; 2001 Jul; 7(7):778-9. PubMed ID: 11433339
    [No Abstract]   [Full Text] [Related]  

  • 24. Games played by rogue proteins in prion disorders and Alzheimer's disease.
    Aguzzi A; Haass C
    Science; 2003 Oct; 302(5646):814-8. PubMed ID: 14593165
    [TBL] [Abstract][Full Text] [Related]  

  • 25. From microbes to prions the final proof of the prion hypothesis.
    Zou WQ; Gambetti P
    Cell; 2005 Apr; 121(2):155-7. PubMed ID: 15851020
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of oligomeric prion-protein aggregates in a mouse model of prion disease.
    Sasaki K; Minaki H; Iwaki T
    J Pathol; 2009 Sep; 219(1):123-30. PubMed ID: 19479969
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of prions in blood.
    Castilla J; Saá P; Soto C
    Nat Med; 2005 Sep; 11(9):982-5. PubMed ID: 16127436
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnosing prion diseases: needs, challenges and hopes.
    Soto C
    Nat Rev Microbiol; 2004 Oct; 2(10):809-19. PubMed ID: 15378045
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Curative properties of antibodies against prion protein: a comparative in vitro study of monovalent fragments and divalent antibodies.
    Alexandrenne C; Hanoux V; Dkhissi F; Boquet D; Couraud JY; Wijkhuisen A
    J Neuroimmunol; 2009 Apr; 209(1-2):50-6. PubMed ID: 19232746
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Generation of monoclonal antibody that distinguishes PrPSc from PrPC and neutralizes prion infectivity.
    Horiuchi M; Karino A; Furuoka H; Ishiguro N; Kimura K; Shinagawa M
    Virology; 2009 Nov; 394(2):200-7. PubMed ID: 19766283
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Unfolding chaperone as a prion protein relating molecule].
    Hachiya NS; Sakasegawa Y; Kaneko K
    Rinsho Shinkeigaku; 2003 Nov; 43(11):817-9. PubMed ID: 15152473
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spongiform diseases. Waiting for the final experiment.
    Enserink M
    Science; 2005 Dec; 310(5755):1758. PubMed ID: 16357238
    [No Abstract]   [Full Text] [Related]  

  • 33. A mathematical analysis of the dynamics of prion proliferation.
    Greer ML; Pujo-Menjouet L; Webb GF
    J Theor Biol; 2006 Oct; 242(3):598-606. PubMed ID: 16753184
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peptides and proteins in neurodegenerative disease: helix propensity of a polypeptide containing helix 1 of the mouse prion protein studied by NMR and CD spectroscopy.
    Liu A; Riek R; Zahn R; Hornemann S; Glockshuber R; Wüthrich K
    Biopolymers; 1999; 51(2):145-52. PubMed ID: 10397798
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathogenesis of prion diseases: current status and future outlook.
    Aguzzi A; Heikenwalder M
    Nat Rev Microbiol; 2006 Oct; 4(10):765-75. PubMed ID: 16980938
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Guanidine hydrochloride extraction and detection of prion proteins in mouse and hamster prion diseases by ELISA.
    Kang SC; Li R; Wang C; Pan T; Liu T; Rubenstein R; Barnard G; Wong BS; Sy MS
    J Pathol; 2003 Apr; 199(4):534-41. PubMed ID: 12635145
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biological and biochemical characteristics of prion strains conserved in persistently infected cell cultures.
    Arima K; Nishida N; Sakaguchi S; Shigematsu K; Atarashi R; Yamaguchi N; Yoshikawa D; Yoon J; Watanabe K; Kobayashi N; Mouillet-Richard S; Lehmann S; Katamine S
    J Virol; 2005 Jun; 79(11):7104-12. PubMed ID: 15890950
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of rafts in the fibrillization and aggregation of prions.
    Pinheiro TJ
    Chem Phys Lipids; 2006 Jun; 141(1-2):66-71. PubMed ID: 16647049
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Binding of disease-associated prion protein to plasminogen.
    Fischer MB; Roeckl C; Parizek P; Schwarz HP; Aguzzi A
    Nature; 2000 Nov; 408(6811):479-83. PubMed ID: 11100730
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An immunoassay for the pathological form of the prion protein based on denaturation and time resolved fluorometry.
    Dabaghian RH; Barnard G; McConnell I; Clewley JP
    J Virol Methods; 2006 Mar; 132(1-2):85-91. PubMed ID: 16219367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.